Anzeige
Erschienen in:
01.12.2015 | Original article
Target lesion calcification and risk of adverse outcomes in patients with drug-eluting stents
A meta-analysis
Erschienen in: Herz | Ausgabe 8/2015
Einloggen, um Zugang zu erhaltenAbstract
Background
Studies focusing on the relationship between calcified lesions and adverse outcomes in the drug-eluting stent (DES) era have presented inconsistent conclusions. The aim of this study was to assess the association between target lesion calcification and adverse outcomes in patients undergoing DES implantation.
Methods
A systematic search was conducted on Medline (Ovid SP, 1946 to 28 February 2014), Embase (Ovid SP, 1974 to 28 February 2014), and the Chinese Biomedical Literature Database (CBM, 1978 to 28 February 2014). Abstracts from the 2012 and 2013 scientific meetings of the American College of Cardiology and American Heart Association were manually searched. Hazard ratios (HRs) were pooled using a fixed or random effects model in the context of heterogeneity.
Results
A total of 13 studies comprising 66,361 patients were included. Target lesion calcification was associated with an increased risk of all-cause mortality (HR = 1.41; 95 % CI = 1.27–1.56), cardiac death (HR = 1.97; 95 % CI = 1.68–2.31), myocardial infarction (HR = 1.33; 95 % CI = 1.13–1.57), target lesion revascularization (TLR; HR 1.47, 95 % CI 1.18–1.83), stent thrombosis (HR 1.63, 95 % CI 1.36–1.96), and major cardiovascular events (HR 1.37, 95 % CI 1.19–1.58). The results proved robust in subgroup analyses for TLR and stent thrombosis.
Conclusion
Calcified target lesions are risk factors for adverse outcomes in the DES era. Further studies focusing on comprehensive therapy in patients with coronary calcification are urgently needed.